Kathryn Jean Boor
CIK: 0001761826
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct16.9K shares- - May 1, 2025IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
Award(A)DirectRestricted Stock Units
2.6K shares- - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct2.4K shares- - Dec 5, 2024SRPT
Sarepta Therapeutics, Inc.
Sale(S)Direct1.6K shares at avg. $125.55$205K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  SRPT Sarepta Therapeutics, Inc. | Award(A) | 16,875 | - | $0 | Direct |
| May 1, 2025 |  IFF INTERNATIONAL FLAVORS & FRAGRANCES INC | Award(A) Restricted Stock Units | 2,569 | - | - | Direct |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 2,383 | - | - | Direct |
| Dec 5, 2024 | SRPT Sarepta Therapeutics, Inc. | Sale(S) | 1,636 | $125.55 | $205,400 | Direct |
1-4 of 4 transactions
About Boor Kathryn Jean
Boor Kathryn Jean (SEC CIK 0001761826) files insider reports with the SEC as Director of Sarepta Therapeutics, Inc. (SRPT) and Director of INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF).
Signal8 holds 4 ownership filings by Boor Kathryn Jean, all Form 4s, filed between Dec 6, 2024 and Jun 5, 2026. Those filings report 4 transactions, from Dec 5, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Boor Kathryn Jean's filings is in CAMBRIDGE, MA.
Recent filings by Boor Kathryn Jean
Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)
- Wong Ryan Ho-Yan, Chief Financial Officer
- Estepan Ian Michael, Chief Operating Officer
- Rothfuss Cristin, EVP, General Counsel
- Rodino-Klapac Louise, President, R&D and Tech Ops
- SEVERINO MICHAEL, Chief Executive Officer
- Mayo Stephen, Director